Literature DB >> 19854222

Performance of HSV-2 type specific serological tests in men in Kenya.

Musa Otieno Ng'ayo1, David Friedrich, King K Holmes, Elizabeth Bukusi, Rhoda Ashley Morrow.   

Abstract

This study compared five serological tests with Western blot from University of Washington to determine the most accurate method for detecting antibodies to herpes simplex virus type 2 (HSV-2) in a male population in Kisumu, Kenya. A random sample of 250 fishermen from 18 beaches along Lake Victoria underwent serological testing by two generations of the HerpeSelect HSV-2 ELISA ("Focus Gen 1" and "Focus Gen 2"), Kalon HSV-2 ELISA ("Kalon"), Biokit HSV-2 Rapid Test ("Biokit"), and HerpeSelect Express Rapid HSV-2 ("Express") against the Western blot test ("WB") as the "gold standard". Sensitivity and specificity of tests in this population with a high prevalence of HSV-2 (58% by WB) were: Focus Gen 1: 98.6% and 63.5%; Focus Gen 2: 99.3% and 52.3%; Biokit: 66% and 90.9%; Express: 99.3% and 44.3% and Kalon: 98.6% and 85.7%. Increasing the positive cut-off value improved the specificity of the Focus Gen 2-84.9% and Kalon to 92.2%. Focus Gen 2 offered no improvement in specificity over that of Focus Gen 1. Neither rapid assay could be recommended as either a stand-alone assay or as a confirmatory test. The results of Kalon using a cut-off of 1.5 were the most concordant with those of WB for all the approaches tested. However, low positive Kalon test results should be interpreted with caution as they could reflect early seroconversion or false positive results. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19854222      PMCID: PMC2820239          DOI: 10.1016/j.jviromet.2009.10.009

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  24 in total

1.  Premarket evaluation of the POCkit HSV-2 type-specific serologic test in culture-documented cases of genital herpes simplex virus type 2 [see comment].

Authors:  R L Ashley; A Wald; M Eagleton
Journal:  Sex Transm Dis       Date:  2000-05       Impact factor: 2.830

2.  Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2.

Authors:  Rhoda Ashley-Morrow; Elizabeth Krantz; Anna Wald
Journal:  Sex Transm Dis       Date:  2003-04       Impact factor: 2.830

3.  Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans.

Authors:  Oliver Laeyendecker; Charla Henson; Ronald H Gray; Ruby H-N Nguyen; Bobbi Jo Horne; Maria J Wawer; David Serwadda; Noah Kiwanuka; Rhoda Ashley Morrow; Wayne Hogrefe; Thomas C Quinn
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

4.  Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations.

Authors:  Eddy van Dyck; Anne Buvé; Helen A Weiss; Judith R Glynn; David W G Brown; Bénédicte De Deken; John Parry; Richard J Hayes
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

Review 5.  Performance and use of HSV type-specific serology test kits.

Authors:  Rhoda L Ashley
Journal:  Herpes       Date:  2002-07

6.  Sexual and demographic determinants for herpes simplex virus type 2 among fishermen along Lake Victoria, Kenya.

Authors:  M O Ng'ayo; E Bukusi; R A Morrow; A Rowhani-Rahbar; B A Obare; D Friedrich; K K Holmes
Journal:  Sex Transm Infect       Date:  2007-12-20       Impact factor: 3.519

7.  Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection.

Authors:  Anna Wald; Rhoda Ashley-Morrow
Journal:  Clin Infect Dis       Date:  2002-10-15       Impact factor: 9.079

8.  Detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition.

Authors:  Wayne Hogrefe; Xin Su; James Song; Rhoda Ashley; Lilly Kong
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

9.  Performance of the focus and Kalon enzyme-linked immunosorbent assays for antibodies to herpes simplex virus type 2 glycoprotein G in culture-documented cases of genital herpes.

Authors:  Rhoda Ashley Morrow; David Friedrich; Elizabeth Krantz
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

10.  Understanding the uneven spread of HIV within Africa: comparative study of biologic, behavioral, and contextual factors in rural populations in Tanzania and Zimbabwe.

Authors:  J Ties Boerma; Simon Gregson; Constance Nyamukapa; Mark Urassa
Journal:  Sex Transm Dis       Date:  2003-10       Impact factor: 2.830

View more
  11 in total

1.  Using biomarkers to assess the validity of sexual behavior reporting across interview modes among young women in Kampala, Uganda.

Authors:  Christine A Kelly; Paul C Hewett; Barbara S Mensch; Johanna C Rankin; Samuel L Nsobya; Samuel Kalibala; Pamela N Kakande
Journal:  Stud Fam Plann       Date:  2014-03

2.  Disclosure of HSV-2 serological test results in the context of an adolescent HIV prevention trial in Kenya.

Authors:  Denise Dion Hallfors; Hyunsan Cho; Isabella I Mbai; Benson W Millimo; Carolyne Atieno; David Okumu; Winnie K Luseno; Shane Hartman; Carolyn T Halpern; Marcia M Hobbs
Journal:  Sex Transm Infect       Date:  2015-07-02       Impact factor: 3.519

3.  Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries.

Authors:  Andrew Mujugira; Rhoda Ashley Morrow; Connie Celum; Jairam Lingappa; Sinead Delany-Moretlwe; Kenneth H Fife; Renee Heffron; Guy De Bruyn; Brigitte Homawoo; Etienne Karita; Nelly Mugo; Bellington Vwalika; Jared M Baeten
Journal:  Sex Transm Infect       Date:  2011-02-09       Impact factor: 3.519

Review 4.  Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract Shedding.

Authors:  Christine Johnston; Lawrence Corey
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

Review 5.  Light microscopy, culture, molecular, and serologic methods for detection of herpes simplex virus.

Authors:  Neil W Anderson; Blake W Buchan; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2013-10-16       Impact factor: 5.948

6.  An Assessment of Risk Factors for Herpes Simplex Virus Type 2 Infection in Malawian Women Using 2 Classifications for the HerpeSelect 2 Test.

Authors:  Payal Chakraborty; Alison H Norris; Sarah Huber-Krum; Sarah Garver; Robert B Hood; Venson Banda; Allahna Esber; Carr Reese Patricia; Robert Krysiak; Abigail Norris Turner
Journal:  Sex Transm Dis       Date:  2020-03       Impact factor: 3.868

7.  Prevalence and incidence estimation of HSV-2 by two IgG ELISA methods among South African women at high risk of HIV.

Authors:  Irith De Baetselier; Joris Menten; Vicky Cuylaerts; Khatija Ahmed; Jennifer Deese; Lut Van Damme; Tania Crucitti
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

8.  Use of HIV and HSV-2 biomarkers in sub-saharan adolescent prevention research: a comparison of two approaches.

Authors:  Winnie K Luseno; Denise Dion Hallfors; Hyunsan Cho; Bonita J Iritani; Joel Adze; Simbarashe Rusakaniko; Isabella Mbai; Benson Milimo; Marcia Hobbs
Journal:  J Prim Prev       Date:  2014-06

9.  Seroprevalence of Herpes Simplex Virus type-2 (HSV-2) among pregnant women who participated in a national HIV surveillance activity in Haiti.

Authors:  Jean Wysler Domercant; Frantz Jean Louis; Erin Hulland; Mark Griswold; Jocelyne Andre-Alboth; Tun Ye; Barbara J Marston
Journal:  BMC Infect Dis       Date:  2017-08-18       Impact factor: 3.090

10.  Remoteness influences access to sexual partners and drives patterns of viral sexually transmitted infection prevalence among nomadic pastoralists.

Authors:  Ashley Hazel; James Holland Jones
Journal:  PLoS One       Date:  2018-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.